False
False
Recommended
False
Related Content
Caribou Halts Allogeneic CAR T Programs as Funding Pressures Mount
October 12, 2026
2 min read
“Caribou’s story has taken a heartbreaking turn,” says CEO Rachel Haurwitz, with the CRISPR-focused biotech set to discontinue vispa-cel and CB-011, and reduce its workforce
This Month’s Manufacturing Moves
October 12, 2026
5 min read
Bayer plans a $2.2 billion Ohio campus, Genentech breaks ground in Oregon, and new investments support vaccine production, downstream processing, and manufacturing in orbit
Prula-cel Shows Early Promise in Lupus
October 8, 2026
2 min read
Adicet Bio reports 12-month remission and renal response data for its allogeneic gamma delta CAR T therapy
Building a Pre-Disease Data Map
October 7, 2026
2 min read
Mayo Clinic and Thermo Fisher launch a large-scale multi-omics resource designed to reveal disease before symptoms appear